Optimize Clinical Laboratory Diagnosis of COVID-19 from Suspect Cases by Likelihood Ratio of SARS-CoV-2 IgM and IgG antibody
View ORCID ProfileFeng Yangchun
doi: https://doi.org/10.1101/2020.04.07.20053660
Feng Yangchun
The Clinical Laboratory Center, The Third Hospital Affliated to Xinjiang Medical University, 830011, Urumqi, China
Data Availability
all data are publicly available,Which can contact the corresponding author for the article data.
Posted April 08, 2020.
Optimize Clinical Laboratory Diagnosis of COVID-19 from Suspect Cases by Likelihood Ratio of SARS-CoV-2 IgM and IgG antibody
Feng Yangchun
medRxiv 2020.04.07.20053660; doi: https://doi.org/10.1101/2020.04.07.20053660
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (626)
- Anesthesia (162)
- Cardiovascular Medicine (2359)
- Dermatology (206)
- Emergency Medicine (377)
- Epidemiology (11748)
- Forensic Medicine (10)
- Gastroenterology (700)
- Genetic and Genomic Medicine (3714)
- Geriatric Medicine (348)
- Health Economics (632)
- Health Informatics (2384)
- Health Policy (928)
- Hematology (340)
- HIV/AIDS (776)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (397)
- Neurology (3477)
- Nursing (197)
- Nutrition (522)
- Oncology (1813)
- Ophthalmology (534)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (232)
- Palliative Medicine (66)
- Pathology (445)
- Pediatrics (1028)
- Primary Care Research (417)
- Public and Global Health (6122)
- Radiology and Imaging (1269)
- Respiratory Medicine (825)
- Rheumatology (379)
- Sports Medicine (320)
- Surgery (398)
- Toxicology (50)
- Transplantation (171)
- Urology (145)